Relevant to GIP–GLP-1 interaction is evidence that GIP receptor gene polymorphisms can alter receptor signalling sufficiently to modify the risk and progression of type 2 diabetes [50]. This evidence concerns the gene GCG and type 2 diabetes mellitus.